Concepts (144)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Deglutition Disorders | 9 | 2020 | 297 | 3.520 |
Why?
|
| Aphasia | 8 | 2022 | 119 | 3.150 |
Why?
|
| Stroke | 15 | 2022 | 2163 | 2.920 |
Why?
|
| Enteral Nutrition | 4 | 2019 | 157 | 2.060 |
Why?
|
| Gastrostomy | 4 | 2017 | 110 | 2.060 |
Why?
|
| Stroke Rehabilitation | 4 | 2021 | 335 | 1.590 |
Why?
|
| Speech | 3 | 2019 | 118 | 1.400 |
Why?
|
| Brain | 9 | 2022 | 2176 | 1.390 |
Why?
|
| Nerve Net | 2 | 2021 | 181 | 1.340 |
Why?
|
| Gastroscopy | 2 | 2016 | 45 | 1.080 |
Why?
|
| Device Removal | 2 | 2017 | 100 | 1.050 |
Why?
|
| Deglutition | 5 | 2020 | 221 | 0.990 |
Why?
|
| Language | 4 | 2022 | 120 | 0.870 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 4 | 2021 | 239 | 0.870 |
Why?
|
| White Matter | 3 | 2021 | 174 | 0.790 |
Why?
|
| Recovery of Function | 3 | 2021 | 506 | 0.790 |
Why?
|
| Connectome | 4 | 2022 | 92 | 0.710 |
Why?
|
| Leukoencephalopathies | 1 | 2019 | 13 | 0.690 |
Why?
|
| Cerebral Ventricles | 1 | 2019 | 36 | 0.680 |
Why?
|
| Transcranial Direct Current Stimulation | 1 | 2021 | 111 | 0.660 |
Why?
|
| Retrospective Studies | 15 | 2022 | 7277 | 0.650 |
Why?
|
| Eating | 1 | 2019 | 119 | 0.630 |
Why?
|
| Middle Aged | 20 | 2022 | 21147 | 0.630 |
Why?
|
| Brain Injuries | 1 | 2021 | 268 | 0.630 |
Why?
|
| Dominance, Cerebral | 1 | 2018 | 65 | 0.620 |
Why?
|
| Aged | 17 | 2022 | 14862 | 0.610 |
Why?
|
| Magnetic Resonance Imaging | 10 | 2022 | 2223 | 0.610 |
Why?
|
| Weights and Measures | 1 | 2017 | 5 | 0.610 |
Why?
|
| Adult | 18 | 2022 | 21403 | 0.540 |
Why?
|
| Feeding and Eating Disorders | 1 | 2017 | 106 | 0.530 |
Why?
|
| Disability Evaluation | 1 | 2017 | 298 | 0.520 |
Why?
|
| Humans | 31 | 2022 | 68618 | 0.470 |
Why?
|
| Guideline Adherence | 1 | 2016 | 287 | 0.460 |
Why?
|
| Male | 21 | 2022 | 37321 | 0.450 |
Why?
|
| Patient Readmission | 1 | 2016 | 267 | 0.450 |
Why?
|
| Sepsis | 1 | 2016 | 233 | 0.440 |
Why?
|
| Female | 20 | 2022 | 38074 | 0.440 |
Why?
|
| Aged, 80 and over | 7 | 2019 | 4848 | 0.430 |
Why?
|
| Brain Ischemia | 1 | 2019 | 665 | 0.430 |
Why?
|
| Brain Mapping | 5 | 2022 | 532 | 0.410 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2016 | 504 | 0.400 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 772 | 0.390 |
Why?
|
| Radiation Dosage | 5 | 2021 | 419 | 0.370 |
Why?
|
| Barium | 3 | 2021 | 52 | 0.360 |
Why?
|
| Surveys and Questionnaires | 1 | 2017 | 2800 | 0.340 |
Why?
|
| Neural Pathways | 2 | 2021 | 324 | 0.330 |
Why?
|
| Barium Sulfate | 2 | 2021 | 66 | 0.330 |
Why?
|
| Axons | 2 | 2021 | 139 | 0.330 |
Why?
|
| Radiation Exposure | 2 | 2021 | 84 | 0.330 |
Why?
|
| Electroencephalography | 2 | 2021 | 418 | 0.300 |
Why?
|
| Patient Discharge | 3 | 2019 | 294 | 0.290 |
Why?
|
| Florida | 2 | 2016 | 221 | 0.260 |
Why?
|
| Fluoroscopy | 4 | 2021 | 152 | 0.260 |
Why?
|
| Databases, Factual | 3 | 2017 | 622 | 0.250 |
Why?
|
| Time Factors | 3 | 2019 | 4655 | 0.250 |
Why?
|
| Contrast Media | 2 | 2019 | 595 | 0.250 |
Why?
|
| Reproducibility of Results | 3 | 2019 | 2077 | 0.240 |
Why?
|
| Multivariate Analysis | 2 | 2016 | 1046 | 0.220 |
Why?
|
| Language Disorders | 1 | 2022 | 22 | 0.210 |
Why?
|
| Logistic Models | 2 | 2016 | 1420 | 0.210 |
Why?
|
| Drug Resistant Epilepsy | 1 | 2021 | 44 | 0.190 |
Why?
|
| Bronchiectasis | 1 | 2021 | 25 | 0.190 |
Why?
|
| Photic Stimulation | 1 | 2021 | 229 | 0.190 |
Why?
|
| Acoustic Stimulation | 1 | 2021 | 206 | 0.190 |
Why?
|
| Mycobacterium Infections, Nontuberculous | 1 | 2021 | 37 | 0.190 |
Why?
|
| Radiometry | 2 | 2018 | 64 | 0.180 |
Why?
|
| Pharynx | 2 | 2018 | 89 | 0.180 |
Why?
|
| Temporal Lobe | 1 | 2021 | 125 | 0.180 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2021 | 211 | 0.180 |
Why?
|
| Aphasia, Broca | 1 | 2019 | 11 | 0.170 |
Why?
|
| Leukoaraiosis | 1 | 2019 | 14 | 0.170 |
Why?
|
| Speech Production Measurement | 1 | 2019 | 14 | 0.170 |
Why?
|
| Lung Diseases | 1 | 2021 | 175 | 0.170 |
Why?
|
| Cineradiography | 1 | 2019 | 12 | 0.170 |
Why?
|
| Longitudinal Studies | 2 | 2021 | 1054 | 0.170 |
Why?
|
| Nerve Fibers | 1 | 2019 | 77 | 0.170 |
Why?
|
| Brain Diseases | 1 | 2019 | 78 | 0.160 |
Why?
|
| Speech-Language Pathology | 1 | 2019 | 24 | 0.160 |
Why?
|
| Fibroblast Growth Factors | 1 | 2018 | 51 | 0.160 |
Why?
|
| Case-Control Studies | 2 | 2021 | 1553 | 0.150 |
Why?
|
| Thyroid Gland | 1 | 2018 | 67 | 0.150 |
Why?
|
| Larynx | 1 | 2018 | 49 | 0.150 |
Why?
|
| Risk Adjustment | 1 | 2017 | 49 | 0.150 |
Why?
|
| Parkinson Disease | 1 | 2020 | 272 | 0.150 |
Why?
|
| Axis, Cervical Vertebra | 1 | 2017 | 5 | 0.150 |
Why?
|
| Diskectomy | 1 | 2017 | 12 | 0.140 |
Why?
|
| Frontal Lobe | 1 | 2018 | 156 | 0.140 |
Why?
|
| Epilepsy | 1 | 2021 | 336 | 0.140 |
Why?
|
| Administrative Claims, Healthcare | 1 | 2016 | 7 | 0.140 |
Why?
|
| Skilled Nursing Facilities | 1 | 2016 | 30 | 0.140 |
Why?
|
| Spinal Fusion | 1 | 2017 | 90 | 0.130 |
Why?
|
| Chronic Disease | 1 | 2021 | 1330 | 0.130 |
Why?
|
| Treatment Outcome | 2 | 2019 | 7029 | 0.130 |
Why?
|
| Self Report | 1 | 2017 | 371 | 0.130 |
Why?
|
| Evidence-Based Practice | 1 | 2017 | 146 | 0.130 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 2279 | 0.130 |
Why?
|
| Inpatients | 1 | 2017 | 208 | 0.130 |
Why?
|
| Time-to-Treatment | 1 | 2016 | 117 | 0.130 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 3259 | 0.120 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 546 | 0.120 |
Why?
|
| Odds Ratio | 1 | 2016 | 880 | 0.120 |
Why?
|
| Risk Assessment | 2 | 2019 | 2007 | 0.110 |
Why?
|
| Aging | 1 | 2019 | 911 | 0.110 |
Why?
|
| Length of Stay | 1 | 2016 | 780 | 0.110 |
Why?
|
| Comorbidity | 1 | 2017 | 1426 | 0.110 |
Why?
|
| Cohort Studies | 3 | 2022 | 2358 | 0.090 |
Why?
|
| Risk Factors | 2 | 2018 | 5731 | 0.090 |
Why?
|
| Postoperative Complications | 1 | 2017 | 1615 | 0.080 |
Why?
|
| Adolescent | 4 | 2022 | 8912 | 0.080 |
Why?
|
| Monte Carlo Method | 2 | 2018 | 124 | 0.080 |
Why?
|
| Child | 3 | 2021 | 6405 | 0.060 |
Why?
|
| Infant | 2 | 2021 | 2891 | 0.050 |
Why?
|
| Language Tests | 1 | 2022 | 36 | 0.050 |
Why?
|
| Semantics | 1 | 2022 | 37 | 0.050 |
Why?
|
| Psycholinguistics | 1 | 2021 | 10 | 0.050 |
Why?
|
| Asymptomatic Infections | 1 | 2021 | 6 | 0.050 |
Why?
|
| Nontuberculous Mycobacteria | 1 | 2021 | 22 | 0.050 |
Why?
|
| Scalp | 1 | 2021 | 47 | 0.050 |
Why?
|
| Electrodes | 1 | 2021 | 147 | 0.050 |
Why?
|
| Forecasting | 1 | 2021 | 277 | 0.040 |
Why?
|
| Young Adult | 2 | 2021 | 5717 | 0.040 |
Why?
|
| Seizures | 1 | 2021 | 279 | 0.040 |
Why?
|
| Statistics, Nonparametric | 1 | 2019 | 306 | 0.040 |
Why?
|
| Vascular Stiffness | 1 | 2018 | 31 | 0.040 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2019 | 79 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2020 | 517 | 0.040 |
Why?
|
| Cerebral Cortex | 1 | 2021 | 415 | 0.040 |
Why?
|
| Hyoid Bone | 1 | 2017 | 10 | 0.040 |
Why?
|
| Vascular Calcification | 1 | 2018 | 131 | 0.040 |
Why?
|
| Endothelium, Vascular | 1 | 2018 | 371 | 0.030 |
Why?
|
| Lung | 1 | 2021 | 849 | 0.030 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2018 | 161 | 0.030 |
Why?
|
| Observer Variation | 1 | 2017 | 330 | 0.030 |
Why?
|
| Video Recording | 1 | 2017 | 145 | 0.030 |
Why?
|
| Software | 1 | 2018 | 418 | 0.030 |
Why?
|
| Medicare | 1 | 2017 | 319 | 0.030 |
Why?
|
| Sex Factors | 1 | 2019 | 1266 | 0.030 |
Why?
|
| Incidence | 1 | 2019 | 1603 | 0.030 |
Why?
|
| Age Factors | 1 | 2019 | 1864 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2017 | 867 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2018 | 2455 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 2324 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 940 | 0.020 |
Why?
|
| United States | 1 | 2017 | 7367 | 0.020 |
Why?
|